Panacea Biotec Share Price

Panacea Biotec

CMP as on 19-May-22 15:58

₹ 166.10
7.65 4.83%

Open

₹ 159.95

Turnover (lac)

₹ 1,025

Prev. Close

₹ 158.45

Day's Vol (shares)

₹ 6,17,097

Day's Range (₹)

₹ 159.95
₹ 174.25

CMP as on19-May-22 15:48

₹ 166.30
7.85 4.95%

Open

₹ 158.80

Turnover (lac)

₹ 149

Prev. Close

₹ 158.45

Day's Vol (shares)

₹ 99,285

Day's Range

₹ 158.80
₹ 174.25

Corporate Action

Go
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 09-May-2022 - -
PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 18/05/2022 inter alia to consider and approve the Standalone and Consolidated Audited Financial Results for the Quarter / Financial Year ended March 31 2022. Further pursuant to Regulation 46(2) of the SEBI LODR Regulations notice of the said meeting is also being uploaded on the website of the Company. Further with reference to our earlier announcement dated March 31 2022 intimating the Closure of Trading Window pursuant to the Companys Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time we would like to inform that the trading window of the Company shall remain closed for all Designated Persons of the Company and Material Subsidiaries of the Company till 48 hours after the declaration of the financial results by the Company i.e. till May 20 2022.
Board Meeting - 03-Feb-2022 - -
PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter and nine months ended December 31 2021. Further pursuant to Regulation 46(2) of the SEBI LODR Regulations notice of the said meeting is also being uploaded on the website of the Company. Further with reference to our earlier announcement dated December 31 2021 intimating the Closure of Trading Window pursuant to the Companys Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations 2015 as amended from time to time we would like to inform that the trading window of the Company shall remain closed for all Designated Persons of the Company till February 16 2022 and the same will re-open from February 17 2022. We would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. February 14, 2022, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and nine months ended December 31, 2021. Pursuant to Regulation 47(1)(b) of SEBI LODR Regulations, the Extract of Statement of above said financial results for the quarter and nine months ended December 31, 2021 in the Format as prescribed in Annexure I of SEBI Circular No. CIR/CFD/FAC/62/2016 dated 05.07.2016 is being sent for publication in newspapers. The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 04:00 P.M. We request you to kindly bring the above information to the notice of your members. (As Per BSE Announcement Dated 14.02.2022)
Board Meeting - 25-Jan-2022 - -
PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2022 inter alia to consider and approve the proposal of raising funds in such manner and on such terms as may be decided by the Board of Directors of the Company and / or its subsidiary company subject to such regulatory /statutory approvals as may be required. The Board would also consider convening Extra-ordinary General Meeting of its shareholders for seeking their approval in accordance with the relevant provisions of the Act. Further the trading window of the Company is already closed for all Designated Persons of the Company from January 01 2022 and shall continue to remain closed till completion of 48 hours from the announcement to the Stock Exchanges regarding Unaudited financial results of the Company for the quarter and nine months ended December 31 2021. We would like to inform that the Board of Directors in its meeting held on 01.02.200 had: taken on record the resolution passed by the Companys wholly-owned subsidiary for sale, transfer or disposal of its domestic business assets constituting its pharmaceutical formulations brands in India and Nepal including related trademarks, copyrights and such other intellectual property as may be agreed, inventories, etc. to Mankind Pharma Limited (Buyer) and/or subsidiaries of Buyer; and approved the said Transaction. In the said meeting, the Board had also convened an Extra-ordinary General Meeting of the Company on Saturday, February 26, 2022 at 11.30 AM through Video Conferencing / Other Audio-Visual Means. The meeting of the Board of Directors commenced at 11:30 A.M. and concluded at 12:15 P.M. (As Per BSE Announcement dated on 01.02.2022)
Board Meeting - 02-Nov-2021 - -
Quarterly Results In continuation to our letter dated November 02, 2021 and pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of Directors of the Company has, at its meeting held today, i.e. November 12, 2021, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter and half year ended September 30, 2021. The same were also reviewed by the Audit Committee in its meeting held earlier on November 12, 2021. The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 05:15 P.M. We request you to kindly bring the above information to the notice of your members (As per BSE Announcement Dated on 12/11/2021)
Board Meeting - 15-Jul-2021 - -
PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2021 ,inter alia, to consider and approve the Standalone and Consolidated Unaudited Financial Results (Provisional) for the quarter ended June 30, 2021. Further, pursuant to Regulation 46(2) of the SEBI LODR Regulations, notice of the said meeting is also being uploaded on the website of the Company. Further, with reference to our earlier announcement dated June 30, 2021 intimating the Closure of Trading Window pursuant to the Companys Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform that the trading window of the Company shall remain closed for all Designated Persons of the Company till July 25, 2021 and the same will re-open from July 26, 2021. We would like to inform you that the Board of Directors of the Company has, at its meeting held 23.07.2021, inter-alia, considered and approved the Unaudited Standalone and Consolidated Financial Results (Provisional) of the Company (which have been subjected to Limited Review by the Statutory Auditors) for the quarter ended June 30, 2021. The same were also reviewed by the Audit Committee in its meeting held earlier on July 23, 2021. We wish to further inform you that the Board of Directors has also decided that: i) the 37th Annual General Meeting of the Company will be held on Saturday, September 25, 2021 at 11:30 A.M. through Video Conferencing / Other Audio-Visual Means; and ii) the Register of Members and Share Transfer Books will remain closed from Saturday, September 18, 2021 to Saturday, September 25, 2021 (both days inclusive) for the purpose of Annual General Meeting. The meeting of the Board of Directors commenced at 02:30 P.M. and concluded at 4:00 P.M Panacea Biotec Ltd has informed BSE regarding Outcome of Board Meeting held on July 23, 2021. (As Per BSE Announcement Dated on 23.07.2021) Panacea Biotec Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 18, 2021 to September 25, 2021 (both days inclusive) for the purpose of 37th Annual General Meeting (AGM) of the Company to be held on September 25, 2021. (As per BSE Announcement Dated on 24/7/2021)
Board Meeting - 24-May-2021 - -
PANACEA BIOTEC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/06/2021 ,inter alia, to consider and approve the Standalone and Consolidated Audited Financial Results for the Quarter / Financial Year ended March 31, 2021. Further, pursuant to Regulation 46(2) of the SEBI LODR Regulations, notice of the said meeting is also being uploaded on the website of the Company. Further, with reference to our earlier announcement dated March 31, 2021 intimating the Closure of Trading Window pursuant to the Companys Code of Conduct for Prevention of Insider Trading framed in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, we would like to inform that the trading window of the Company shall remain closed for all Designated Persons of the Company and Material Subsidiaries of the Company till June 04, 2021 and the same will re-open from June 05, 2021 We would like to inform you that the Board of Directors of the Company has, at its meeting held today 02.06.2021, inter-alia, considered and approved the following:- 1. Audited Financial Results (Standalone and Consolidated) of the Company for the Quarter and Financial Year ended March 31, 2021. The same were also reviewed by the Audit Committee in its meeting held earlier on 02.06.2021. 2. Raising of funds by the Company through one or more permissible mechanisms as may be deemed appropriate by the Board, for an amount upto and not exceeding INR 12,000 million or its equivalent in any other currency(ies), in one or more tranches, subject to the approval of the Shareholders of the Company and any other regulatory or statutory approvals, as may be required; and 3. Convening of EGM of the Company on 25.06.2021 at 11:30 A.M. through Video Conferencing / Other Audio-Visual Means. The meeting of the Board of Directors commenced at 02:00 P.M. and concluded at 07:15 P.M. Panacea Biotec Ltd has informed BSE about Outcome of Board Meeting held on June 02, 2021. (As Per BSE Announcement dated on 02.06.2021)
Open ZERO Brokerage Demat Account Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity